These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 14183277)

  • 21. [OBSERVATIONS ON THE TREATMENT OF PULMONARY TUBERCULOSIS WITH ETHYL-ISOTHIAMIDE].
    SPINA G
    G Ital Chemioter; 1963; 10():129-32. PubMed ID: 14074249
    [No Abstract]   [Full Text] [Related]  

  • 22. THE INFLUENCE OF PARA-AMINOSALICYLIC ACID ON THE I-131 METABOLISM.
    MUNKNER T
    Acta Radiol Diagn (Stockh); 1965; ():SUPPL 234:1+. PubMed ID: 14331557
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparative evaluation of blood levels and tolerance of sodium PAS and conjugated PAS and ascorbic acid.
    Schless JM; Inglis RM; Hammond JH; Hale JM
    Dis Chest; 1966 Dec; 50(6):595-600. PubMed ID: 5964864
    [No Abstract]   [Full Text] [Related]  

  • 24. Para-aminosalicylic acid (PAS) in cavernous pulmonary tuberculosis; oral treatment; comparison between the effects of PAS in oral and transthoracic administration.
    DIFS H
    Acta Tuberc Scand; 1951; 25(2-3):128-63. PubMed ID: 14810565
    [No Abstract]   [Full Text] [Related]  

  • 25. [ETHIONAMIDE IN THE TREATMENT OF PULMONARY TUBERCULOSIS].
    ZIERSKI M
    G Ital Chemioter; 1963; 10():110-7. PubMed ID: 14074246
    [No Abstract]   [Full Text] [Related]  

  • 26. On the reasons for irregular self-administration of PAS.
    das ALMEIDA FN
    Tubercle; 1962 Dec; 43():367-74. PubMed ID: 14012221
    [No Abstract]   [Full Text] [Related]  

  • 27. THE EFFECT OF SYSTEMATIC ADMINISTRATION OF INH ON PRIMARY TUBERCULOSIS IN CHILDHOOD. PRESENTATION OF A "5-YEAR TRIAL".
    MANDE R; HERRAULT A
    Siriraj Hosp Gaz; 1963 Jul; 15():398-406. PubMed ID: 14140373
    [No Abstract]   [Full Text] [Related]  

  • 28. [THE ACTION OF PAS ON THE VESSELS AND ARTERIAL PRESSURE IN EXPERIMENTS].
    BYTCHENKO DA
    Farmakol Toksikol; 1963; 26():306-9. PubMed ID: 14051667
    [No Abstract]   [Full Text] [Related]  

  • 29. [BACTERIOLOGICALLY ACTIVE SERUM CONCENTRATIONS FURNISHED BY THE COMBINED USE OF ISONIAZID AND ALUMINO-CALCIC PAS].
    VIVIEN JN; THIBIER R; LEPEUPLE A
    Rev Tuberc Pneumol (Paris); 1965; 29():250-7. PubMed ID: 14326318
    [No Abstract]   [Full Text] [Related]  

  • 30. TREATMENT OF PULMONARY TUBERCULOSIS. A COMPARATIVE STUDY WITH A NEW DRUG.
    BOLAR SS
    J Indian Med Assoc; 1965 Jan; 44():61-4. PubMed ID: 14262779
    [No Abstract]   [Full Text] [Related]  

  • 31. [COMPARATIVE STUDY OF PAS LEVELS IN BLOOD AND URINE].
    GAJEWSKA E
    Gruzlica (1926); 1964 Nov; 32():1031-4. PubMed ID: 14327143
    [No Abstract]   [Full Text] [Related]  

  • 32. [Oral administration of PAS].
    RENARD J; COULET M; RIMBAULT Y
    Therapie; 1952; 7(4):362-7. PubMed ID: 12984373
    [No Abstract]   [Full Text] [Related]  

  • 33. [COMPARATIVE STUDY BETWEEN THE BACTERIOSTATIC ACTIVITY OF BLOOD SERUM TAKEN AFTER INGESTION OF PARANIAZIDE AND THE BACTERIOSTATIC ACTIVITY OF SERUM TAKEN AFTER INGESTION OF INH AND PAS].
    FOUQUET J; TEYSSIER L
    Rev Tuberc Pneumol (Paris); 1965; 29():173-86. PubMed ID: 14326309
    [No Abstract]   [Full Text] [Related]  

  • 34. [RELATION OF SERUM PAS LEVELS TO THE PREPARATION USED].
    PIKKOLA E; HAAPANEN JH
    Duodecim; 1964; 80():193-9. PubMed ID: 14134512
    [No Abstract]   [Full Text] [Related]  

  • 35. [CHEMO-ANTIBIOTIC THERAPY OF TUBERCULOSIS IN DIABETICS AND ITS REPERCUSSIONS ON GLUCIDE METABOLISM].
    FILLA E; COMENALE D; ROSSI F
    Minerva Med; 1964 Aug; 55():2417-22. PubMed ID: 14192139
    [No Abstract]   [Full Text] [Related]  

  • 36. [On 2 cases of acute hemolytic anemia caused by PAS administration; clinico-pathogenetic remarks].
    BALSAMO V
    Riv Clin Pediatr; 1962 Jun; 69():368-76. PubMed ID: 13966237
    [No Abstract]   [Full Text] [Related]  

  • 37. [Considerations on the behavior of blood and CSF concentrations in children subjected to the introduction of PAS by various routes].
    CARNEVALE A; CUTILLO S
    Pediatria (Rio); 1949; 57(5-6):365-72. PubMed ID: 18137830
    [No Abstract]   [Full Text] [Related]  

  • 38. INJECTIONS ARE NO LONGER NECESSARY IN THE TREATMENT OF RENAL TUBERCULOSIS.
    LATTIMER JK; REILLY RJ; SEGAWA A; WECHSLER H; SIEGEL J; GIRGIS A; GLEASON D
    Trans Am Assoc Genitourin Surg; 1964; 56():140-7. PubMed ID: 14215729
    [No Abstract]   [Full Text] [Related]  

  • 39. [COMPREHENSIVE STUDIES ON A NEW ANTITUBERCULAR AGENT, PASCON. (2) ON ITS CLINICAL EFFECTIVENESS].
    TAKENAKA T; TSUKAMURA M; IMAZU S; TANAKA T
    Iryo; 1964 Apr; 18():207-11. PubMed ID: 14169122
    [No Abstract]   [Full Text] [Related]  

  • 40. [Para-aminosalicylic acid metabolism in the body. VII. Resorption and tolerance of calcium-PAS compound and early results of treatment of pulmonary tuberculosis].
    Owsiński J; Kamińska M; Ostrowska A; Rapf T
    Gruzlica; 1972 Jul; 40(7):635-7. PubMed ID: 5053842
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.